Skip to content

ACCELERON PHARMA INC.

CIK 0001280600

← back to feed
Revenue (TTM)
$109.46M
+14.6% YoY Q3 Nov 2021
Net Income (TTM)
−$236.7M
−46.3% YoY Q3 Nov 2021
EPS Diluted (TTM)
−$3.21
+4.6% YoY Q3 Nov 2021
Gross Margin
—
Q3 Nov 2021
Operating Margin
-216.6%
Q3 Nov 2021
Net Margin
-216.2%
Q3 Nov 2021
Free Cash Flow (TTM)
−$166.65M
Q3 Nov 2021
Cash
$336.46M
Q3 Nov 2021
Total Debt
—
Q3 Nov 2021
Shares Outstanding
61.16M sh
Q3 Nov 2021

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings